Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Hydrated vs Non-Hydrated Octreotide Implant in Acromegaly
NCT00913055Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Feb 2007
- Primary completion
- May 2007
- Modality
- Peptides
01
Overview
A Phase 2 trial of Octreotide long-acting injection in acromegaly, sponsored by Endo International plc. Started Feb 2007; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00913055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00913055.